333 related articles for article (PubMed ID: 33681219)
1. Inflammatory Cell Recruitment in Cardiovascular Disease.
Marchini T; Mitre LS; Wolf D
Front Cell Dev Biol; 2021; 9():635527. PubMed ID: 33681219
[TBL] [Abstract][Full Text] [Related]
2. Inflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.
Saxena A; Russo I; Frangogiannis NG
Transl Res; 2016 Jan; 167(1):152-66. PubMed ID: 26241027
[TBL] [Abstract][Full Text] [Related]
3. Chemokine fractalkine mediates leukocyte recruitment to inflammatory endothelial cells in flowing whole blood: a critical role for P-selectin expressed on activated platelets.
Schulz C; Schäfer A; Stolla M; Kerstan S; Lorenz M; von Brühl ML; Schiemann M; Bauersachs J; Gloe T; Busch DH; Gawaz M; Massberg S
Circulation; 2007 Aug; 116(7):764-73. PubMed ID: 17679613
[TBL] [Abstract][Full Text] [Related]
4. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
Henning RJ; Bourgeois M; Harbison RD
Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
[TBL] [Abstract][Full Text] [Related]
5. Alterations in circulating intercellular adhesion molecule-1 and L-selectin: further evidence for chronic inflammation in ischemic heart disease.
Haught WH; Mansour M; Rothlein R; Kishimoto TK; Mainolfi EA; Hendricks JB; Hendricks C; Mehta JL
Am Heart J; 1996 Jul; 132(1 Pt 1):1-8. PubMed ID: 8701848
[TBL] [Abstract][Full Text] [Related]
6. Anti-inflammatory therapies in myocardial infarction: failures, hopes and challenges.
Huang S; Frangogiannis NG
Br J Pharmacol; 2018 May; 175(9):1377-1400. PubMed ID: 29394499
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological opportunities to control inflammatory diseases through inhibition of the leukocyte recruitment.
Peres RS; Menezes GB; Teixeira MM; Cunha FQ
Pharmacol Res; 2016 Oct; 112():37-48. PubMed ID: 26808082
[TBL] [Abstract][Full Text] [Related]
8. The receptor for activated complement factor 5 (C5aR) conveys myocardial ischemic damage by mediating neutrophil transmigration.
Mueller M; Herzog C; Larmann J; Schmitz M; Hilfiker-Kleiner D; Gessner JE; Theilmeier G
Immunobiology; 2013 Sep; 218(9):1131-8. PubMed ID: 23642836
[TBL] [Abstract][Full Text] [Related]
9. Leukocyte Trafficking in Cardiovascular Disease: Insights from Experimental Models.
Jones DP; True HD; Patel J
Mediators Inflamm; 2017; 2017():9746169. PubMed ID: 28465628
[TBL] [Abstract][Full Text] [Related]
10. Sema3A promotes the resolution of cardiac inflammation after myocardial infarction.
Rienks M; Carai P; Bitsch N; Schellings M; Vanhaverbeke M; Verjans J; Cuijpers I; Heymans S; Papageorgiou A
Basic Res Cardiol; 2017 Jul; 112(4):42. PubMed ID: 28540528
[TBL] [Abstract][Full Text] [Related]
11. Leukocyte diversity in resolving and nonresolving mechanisms of cardiac remodeling.
Tourki B; Halade G
FASEB J; 2017 Oct; 31(10):4226-4239. PubMed ID: 28642328
[TBL] [Abstract][Full Text] [Related]
12. Importance of primary capture and L-selectin-dependent secondary capture in leukocyte accumulation in inflammation and atherosclerosis in vivo.
Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L
J Exp Med; 2001 Jul; 194(2):205-18. PubMed ID: 11457895
[TBL] [Abstract][Full Text] [Related]
13. Heparan sulphate as a regulator of leukocyte recruitment in inflammation.
Kumar AV; Katakam SK; Urbanowitz AK; Gotte M
Curr Protein Pept Sci; 2015; 16(1):77-86. PubMed ID: 25692849
[TBL] [Abstract][Full Text] [Related]
14. Mechanisms of leukocyte recruitment to atherosclerotic lesions: future prospects.
Eriksson EE
Curr Opin Lipidol; 2004 Oct; 15(5):553-8. PubMed ID: 15361791
[TBL] [Abstract][Full Text] [Related]
15. Critical role of P-selectin-dependent rolling in tumor necrosis factor-alpha-induced leukocyte adhesion and extravascular recruitment in vivo.
Månsson P; Zhang XW; Jeppsson B; Johnell O; Thorlacius H
Naunyn Schmiedebergs Arch Pharmacol; 2000 Aug; 362(2):190-6. PubMed ID: 10961383
[TBL] [Abstract][Full Text] [Related]
16. P2Y6 deficiency limits vascular inflammation and atherosclerosis in mice.
Stachon P; Peikert A; Michel NA; Hergeth S; Marchini T; Wolf D; Dufner B; Hoppe N; Ayata CK; Grimm M; Cicko S; Schulte L; Reinöhl J; von zur Muhlen C; Bode C; Idzko M; Zirlik A
Arterioscler Thromb Vasc Biol; 2014 Oct; 34(10):2237-45. PubMed ID: 25104800
[TBL] [Abstract][Full Text] [Related]
17. P-selectin antagonism in inflammatory disease.
Woollard KJ; Chin-Dusting J
Curr Pharm Des; 2010; 16(37):4113-8. PubMed ID: 21247396
[TBL] [Abstract][Full Text] [Related]
18. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans.
Jaakkola K; Jalkanen S; Kaunismäki K; Vänttinen E; Saukko P; Alanen K; Kallajoki M; Voipio-Pulkki LM; Salmi M
J Am Coll Cardiol; 2000 Jul; 36(1):122-9. PubMed ID: 10898423
[TBL] [Abstract][Full Text] [Related]
19. Direct viewing of atherosclerosis in vivo: plaque invasion by leukocytes is initiated by the endothelial selectins.
Eriksson EE; Xie X; Werr J; Thoren P; Lindbom L
FASEB J; 2001 May; 15(7):1149-57. PubMed ID: 11344083
[TBL] [Abstract][Full Text] [Related]
20. Atherosclerosis as an inflammatory disease.
Tuttolomondo A; Di Raimondo D; Pecoraro R; Arnao V; Pinto A; Licata G
Curr Pharm Des; 2012; 18(28):4266-88. PubMed ID: 22390643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
